Amino acids
Small building blocks join in a particular order.

Peptides can sound more complicated than they need to. This guide explains what they are, why different peptides attract interest, how the evidence can differ and the language you will meet as you explore.
Peptides are short chains of amino acids — the same building blocks used to make proteins. Their sequence and shape can allow them to act as biological signals, interacting with receptors and pathways involved in processes such as appetite, repair, metabolism, hormones and immune response.
Small building blocks join in a particular order.
The resulting chain has its own sequence and three-dimensional behaviour.
Some peptides can interact with receptors or signalling pathways in the body.
The signal may influence a process such as appetite, tissue repair, hormone release or metabolism.
“Peptide” describes a broad type of molecule, not a single treatment or effect. One peptide may be involved in appetite signalling while another is studied around immune function, pigmentation, tissue repair or reproductive hormones. What matters is the individual compound, its biological target and what research has actually shown.
Some peptide-based medicines have been tested extensively in people and are authorised for specific medical uses. Other compounds are still investigational, with evidence ranging from early human studies to laboratory or animal research. A promising mechanism can explain why researchers are interested, but it is not the same as demonstrating a useful effect in people.
Recovery, weight, energy, cognition, sleep, skin, hormones and healthy ageing all lead into different parts of peptide research. Looking at compounds within the same area makes their potential benefits — and the differences in evidence behind them — much easier to compare.
Interested in recovery? Explore the recovery and repair category, get to know BPC-157 and follow its story through our guide to human studies. If combinations have caught your attention, the Wolverine stack profile explains why BPC-157 and TB-500 are often discussed together.
Start with why people are interested and the most promising part of the research story.
See recurring goals and reported experiences, clearly separated from formal evidence.
Compare published protocols with commonly discussed starting points, timing and course structure.
Open the original papers, trial records and current-status sources when you want the detail.
Amount, concentration and syringe volume are different things. Adding more diluent changes the concentration and therefore the volume needed to measure the same amount. Titration means changing an amount in planned stages over time. Our calculators make those relationships visible and can calculate a schedule you enter; they do not decide what dose or titration schedule is appropriate.
For a worked explanation, open the reconstitution calculator guide. To see how amounts and timing are reported in trials, read the Retatrutide dosage research guide alongside the Retatrutide profile.
Research involving people. It may measure safety, biology or clinical outcomes; not every human study proves a useful treatment.
Laboratory or animal work used to explore mechanisms and early signals before clinical benefit is known.
The amount, route, timing and duration used in one study. It describes that study rather than a personal recommendation.
A planned step-by-step change in dose, usually to reach a target while monitoring tolerability.
How something is given—for example oral, topical, intranasal, subcutaneous or intravenous.
Still being studied and not yet established as an authorised treatment for the use being discussed.
A summary of what people report discussing or doing. It can guide questions but is not clinical proof.
Two or more compounds discussed or studied together. Evidence for each ingredient does not automatically prove the combination.
Save peptides, build plans, set reminders and keep track of your own supplies in a private My Explorer space.